Literature DB >> 2826711

Potentially curative surgery of colon cancer: patterns of failure and survival.

B D Minsky1, C Mies, T A Rich, A Recht, J T Chaffey.   

Abstract

In an effort to determine the patterns of failure and survival of colon cancer, a retrospective review of 294 patients who underwent potentially curative surgery at the New England Deaconess Hospital (NEDH) was performed. For the entire group, the 5-year crude survival rate was 68% and the actuarial rate was 80%. Survival decreased with increasing bowel wall penetration by tumor and the presence of lymph node metastasis. Although survival varied with the tumor site, none of the differences was statistically significant. Other variables, including the grade of adenocarcinoma, size, and the type of surgery had a significant impact on survival. Patterns of failure, expressed as the actuarial incidence of first diagnosed failure at 5 years, were examined by stage and site. There was a trend toward increased failure with increasing bowel wall penetration by tumor and the presence of lymph node metastasis. Abdominal failure, either as the only site or as a component of failure, was the most common type of failure. When compared by site, patients with cecal carcinoma had a significantly lower incidence of local and distant failure than patients with disease in other selected sites. No differences in patterns of failure were seen in patients with carcinomas in the mobile sections of the colon compared with those who had disease arising in the nonmobile sections of the colon. These data may be useful in identifying those patients who might benefit most from adjuvant therapy.

Entities:  

Mesh:

Year:  1988        PMID: 2826711     DOI: 10.1200/JCO.1988.6.1.106

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  27 in total

1.  Intraperitoneal chemotherapy: biologic implications for clinical outcome.

Authors:  J M Daly
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

Review 3.  Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  César P Ramírez Plaza; Manuel A Cobo Dols; Alberto Gómez Portilla; Agustín de la Fuente Perucho
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

Review 4.  Management of peritoneal carcinomatosis from colorectal cancer.

Authors:  Chukwuemeka U Ihemelandu; Perry Shen; John H Stewart; Konstantinos Votanopoulos; Edward A Levine
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

5.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 6.  Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.

Authors:  Csilla Hasovits; Stephen Clarke
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 7.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

8.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.

Authors:  Adrian Cravioto-Villanueva; Magdalena Cavazos; Pedro Luna-Perez; Hector Martinez-Gomez; María Lourdes Ramirez; Juan Solorzano; Hermelindo Montiel; Jesus Esquivel
Journal:  Surg Today       Date:  2016-04-30       Impact factor: 2.549

9.  Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.

Authors:  M A Hammoud; I E McCutcheon; R Elsouki; D Schoppa; Y Z Patt
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

10.  Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies.

Authors:  P Piso; M H Dahlke; N Ghali; I Iesalnieks; M Loss; F Popp; P von Breitenbuch; A Agha; S A Lang; F Kullmann; H J Schlitt
Journal:  Int J Colorectal Dis       Date:  2007-04-26       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.